|

Risk Factors for Stroke or Systemic Embolism in Chinese Patients with Non-Valvular Atrial Fibrillation Registry

RECRUITINGSponsored by China National Center for Cardiovascular Diseases
Actively Recruiting
SponsorChina National Center for Cardiovascular Diseases
Started2023-04-18
Est. completion2024-12-31
Eligibility
Age18 Years – 120 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05598632

Summary

This study is aimed to validate the existing stroke risk stratification model for patients with atrial fibrillation (AF) (CHA2DS2-VASc Score, CHADS2 Score, ATRIA score, ABC score, etc.) and establish a new stroke risk assessment model using a nationwide AF -specific registry in China.

Eligibility

Age: 18 Years – 120 YearsHealthy volunteers accepted
Inclusion Criteria:

* 18 years of age or older; male or female.
* History of documented atrial fibrillation.
* Able to provide written informed consent.

Exclusion Criteria:

* Subjects with moderate or severe mitral stenosis or a mechanical heart valve
* Subjects with previous or planned AF ablation.
* Subjects with previous or planned left atrial appendage closure.
* Subjects unable to cooperate with follow-up after assessment.

Conditions3

Atrial FibrillationHeart DiseaseStroke

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.